Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Heart Rhythm

• Publication date

  2015-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.hrthm.2015.06.038PMID 26142297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.

  2015cited by this paper
• Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

  2014cited by this paper
• Stroke in South Asian countries

  2014cited by this paper
• Global epidemiology of atrial fibrillation

  2014cited by this paper
• Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.

  2014influential reference
• Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.

  2014cited by this paper
• Extravirgin Olive Oil Consumption Reduces Risk of Atrial Fibrillation: The PREDIMED (Prevención con Dieta Mediterránea) Trial

  2014cited by this paper
• Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins?

  2014cited by this paper
• Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.

  2014influential reference
• A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin

  2014cited by this paper
• SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.

  2014cited by this paper
• Impact of Metabolic Syndrome on Left Atrial Electroanatomical Remodeling and Outcomes After Radiofrequency Ablation of Nonvalvular Atrial Fibrillation

  2014cited by this paper
• The effects of fasting in Muslim patients taking warfarin

  2014cited by this paper
• Extravirgin Olive Oil Consumption Reduces Risk of Atrial Fibrillation The PREDIMED (Prevención con Dieta Mediterránea) Trial

  2014influential reference
• Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

  2014cited by this paper
• Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

  2014cited by this paper
• Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

  2014cited by this paper
• Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.

  2014cited by this paper
• Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation

  2013influential reference
• Prevalence, Incidence, and Mortality of Stroke in the Chinese Island Populations: A Systematic Review

  2013cited by this paper
• Update on the management of atrial fibrillation

  2013cited by this paper
• Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

  2013cited by this paper
• Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice

  2013cited by this paper
• Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.

  2013cited by this paper
• Edoxaban versus warfarin in patients with atrial fibrillation.

  2013cited by this paper
• Pharmacokinetics of rivaroxaban after bariatric surgery: a case report

  2013cited by this paper
• ‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747]

  2013cited by this paper
• European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

  2013cited by this paper
• Evaluation of edoxaban in patients with atrial fibrillation and severe renal impairment

  2013cited by this paper
• Effects of Bariatric Surgery on Human Small Artery Function

  2013cited by this paper
• A Systematic Review of Depression and Anxiety in Patients with Atrial Fibrillation: The Mind-Heart Link

  2013cited by this paper
• What Do We Currently Know About Metabolic Syndrome and Atrial Fibrillation?

  2013cited by this paper
• Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)

  2013cited by this paper
• Regional differences in use of antithrombotic therapy for stroke prevention in atrial fibrillation and associated outcomes: European and Asian insights

  2013cited by this paper
• Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies.

  2013cited by this paper
• Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

  2013cited by this paper
• Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.

  2013cited by this paper
• Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy.

  2013cited by this paper
• Global obesity: trends, risk factors and policy implications

  2013cited by this paper
• Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

  2013cited by this paper
• General mechanisms of coagulation and targets of anticoagulants (Section I)

  2013cited by this paper
• Blood Lipid Levels, Lipid-Lowering Medications, and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study

  2012cited by this paper
• Apixaban versus Warfarin in Patients with Atrial Fibrillation

  2012cited by this paper
• Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor

  2012cited by this paper
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

  2012cited by this paper
• Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

  2012cited by this paper
• Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice

  2012cited by this paper
• Population-level intervention strategies and examples for obesity prevention in children.

  2012influential reference
• Atrial fibrillation and the risk of incident dementia: a meta-analysis.

  2012cited by this paper
• Apixaban in patients with atrial fibrillation.

  2011cited by this paper
• Apixaban versus warfarin in patients with atrial fibrillation.

  2011cited by this paper
• Apixaban in patients with atrial fibrillation.

  2011cited by this paper
• The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers

  2011cited by this paper
• Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients.

  2011cited by this paper
• Association between lipid profile and risk of atrial fibrillation.

  2011cited by this paper
• Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic

  2011cited by this paper
• Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

  2011cited by this paper
• Left atrial size and risk for all-cause mortality and ischemic stroke

  2011cited by this paper
• Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation

  2010cited by this paper
• What is associated with low food intake in older people with dementia?

  2010cited by this paper
• Anticoagulação oral em pacientes com fibrilação atrial: das diretrizes à prática clínica

  2010cited by this paper
• Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.

  2010cited by this paper
• Metabolic syndrome predicts the incidence of hepatic steatosis in Koreans.

  2010cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).

  2010cited by this paper
• [Oral anticoagulation in patients with atrial fibrillation: from guidelines to bedside].

  2010cited by this paper
• Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.

  2009cited by this paper
• Regimen complexity and medication nonadherence in elderly patients

  2009cited by this paper
• Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Obesity-related hypertension.

  2009cited by this paper
• Diabetic cardiomyopathy--a distinct disease?

  2009cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Health Care Utilization and Costs by Metabolic Syndrome Risk Factors

  2009cited by this paper
• Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

  2009cited by this paper
• Metabolic Syndrome Pandemic

  2008cited by this paper
• Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study

  2008cited by this paper
• Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review

  2008cited by this paper
• Metabolic syndrome, haemostasis and thrombosis

  2008cited by this paper
• Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.

  2008cited by this paper
• Atrial fibrillation and obesity--results of a meta-analysis.

  2008cited by this paper
• Atrial fibrillation susceptibility in metabolic syndrome: simply the sum of its parts?

  2008cited by this paper
• The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.

  2007cited by this paper
• Effects of bariatric surgery on mortality in Swedish obese subjects.

  2007cited by this paper
• Heritability of Clot Formation, Morphology, and Lysis: The EuroCLOT Study

  2007cited by this paper
• Body Weight Has Limited Influence on the Safety, Tolerability, Pharmacokinetics, or Pharmacodynamics of Rivaroxaban (BAY 59‐7939) in Healthy Subjects

  2007cited by this paper
• Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?

  2007cited by this paper
• Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

  2007cited by this paper
• Metabolic Syndrome: From Global Epidemiology to Individualized Medicine

  2007cited by this paper
• Misuse of antithrombotic therapy in atrial fibrillation patients: frequent, pervasive and persistent

  2007cited by this paper
• Effect of ramipril on the incidence of diabetes.

  2007cited by this paper
• Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

  2007cited by this paper
• Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

  2006cited by this paper
• Mechanisms linking obesity to insulin resistance and type 2 diabetes

  2006cited by this paper
• Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

  2006cited by this paper
• Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men

  2006cited by this paper

• How Emerging Digital Health Technologies Based on Dietary and Physical Activity Regulation Improve Metabolic Syndrome-Related Outcomes in Adolescents: A Systematic Review.

  2026cites this paper
• Metabolic Syndrome and Atrial Cardiomyopathy on the Risk of Stroke Mortality in the General Population

  2025cites this paper
• Surrogate insulin resistance indices are associated with left atrial thrombus in patients with nonvalvular atrial fibrillation

  2025cites this paper
• Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study

  2025cites this paper
• Revealing Left Atrial Dysfunction in Metabolic Syndrome and Atrial Fibrillation

  2024cites this paper
• SIRT3/AMPK signaling pathway regulates lipid metabolism and improves vulnerability to atrial fibrillation in Dahl salt sensitive rats.

  2024cites this paper
• Machine Learning Approaches for Stroke Risk Prediction: Findings from the Suita Study

  2024cites this paper
• 2023 Cardiac Society of Australia and New Zealand Expert Position Statement on Catheter and Surgical Ablation for Atrial Fibrillation.

  2024cites this paper
• Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View

  2023cites this paper
• Modifications of long-term heart rate variability produced in an experimental model of diet-induced metabolic syndrome

  2023cites this paper
• Effect of dietary diversity on incident of disability in community-dwelling older adults with sarcopenia: A 40-month follow-up longitudinal study.

  2023cites this paper
• Metabolic syndrome and hemorrhagic stroke among symptomatic CCMs in the Mexican Hispanic Population

  2023cites this paper
• Early atrial remodeling predicts the risk of cardiovascular events in patients with metabolic syndrome: a retrospective cohort study

  2023cites this paper
• Multiple targets related to mitochondrial function unveiled by metabolomics and proteomics profiles of hearts from atrial fibrillation patients

  2023cites this paper
• Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA2DS2-VASc scores

  2023cites this paper
• Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

  2023cites this paper
• Causal effect of non-alcoholic fatty liver disease on atrial fibrillation.

  2022cites this paper
• The associations between fasting glucose, lipids and uric acid levels strengthen with the decile of uric acid increase and differ by sex.

  2022cites this paper
• QTc Interval is Associated with Atrial Fibrillation in Individuals with Metabolic Syndrome Phenotype

  2022cites this paper
• Pathophysiological aspects of insulin resistance in Atrial Fibrillation: novel therapeutic approaches

  2022cites this paper
• Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure

  2021cites this paper
• Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study

  2021cites this paper
• Modulated Calcium Homeostasis and Release Events Under Atrial Fibrillation and Its Risk Factors: A Meta-Analysis

  2021cites this paper
• Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study

  2020cites this paper
• The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome

  2020cites this paper
• High prevalence of hyperuricaemia and its impact on non-valvular atrial fibrillation: the cross-sectional Guangzhou (China) Heart Study

  2019influential citation
• Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected

  2019cites this paper
• Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey

  2019cites this paper
• The Role of Cardiovascular and Metabolic Comorbidities in the Link between Atrial Fibrillation and Cognitive Impairment: An Appraisal of Current Scientific Evidence

  2019cites this paper
• Atrial fibrillation and its arrhythmogenesis associated with insulin resistance

  2019cites this paper
• Metabolic syndrome and risk of stroke

  2018cites this paper
• Metabolic Syndrome and the Risk of New-Onset Atrial Fibrillation in Middle-Aged East Asian Men.

  2018cites this paper
• Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.

  2018cites this paper
• MicroRNA Expression Profiles Identify Biomarker for Differentiating the Embolic Stroke from Thrombotic Stroke

  2018cites this paper
• Blepharitis as an early sign of metabolic syndrome: a nationwide population-based study

  2017cites this paper
• Influence of Inflammation and Atherosclerosis in Atrial Fibrillation

  2017cites this paper
• Association between γ-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.

  2017cites this paper
• Influence of Inflammation and Atherosclerosis in Atrial Fibrillation

  2017cites this paper
• Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral Anticoagulants: A Review

  2017cites this paper
• Screening for Atrial Fibrillation using Economical and accurate TechnologY (SAFETY)—a pilot study

  2017cites this paper
• Risk Factor Management and Atrial Fibrillation Clinics: Saving the Best for Last?

  2017cites this paper
• Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation

  2016cites this paper
• Dyslipidemia in patients with arterial hypertension and extrasystoles

  2016cites this paper
• Stroke Prevention in Atrial Fibrillation: Focus on Latin America

  2016cites this paper
• The associations between atrial fibrillation and parameters of nutritional status assessment in the general hospital population - a cross-sectional analysis of medical documentation.

  2016cites this paper
• Obesity-Related Diseases and Syndromes: Insulin Resistance, Type 2 Diabetes Mellitus, Non-alcoholic Fatty Liver Disease, Cardiovascular Disease, and Metabolic Syndrome

  2016cites this paper
• Evaluation of the Association Between Retinal Vein Occlusion and the Risk of Atrial Fibrillation Development: A 12-Year, Retrospective Nationwide Cohort Study

  2016cites this paper
• Integrated analysis of dysregulated lncRNA and mRNA expression profiles in pulmonary vein sleeves from patients with long-standing persistent atrial fibrillation

  2016cites this paper